youtube_live
Q3 2026 earnings • released • EPS beat +2.32% • Revenue miss -0.16%
See resultschevron_right
ALC:NYSE
Alcon AG
$74.06
arrow_downward
-1.44%(-1.08) 1D
$70.00
arrow_downward
-5.48% (-4.06)bedtimeAfter hours
Closed: Nov 10, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$74.72
High
$75.70
Low
$72.21
Mkt. cap
30.88B
Avg. vol.
1.87M
Volume
5.31M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
Open
$74.72
High
$75.70
Low
$72.21
Mkt. cap
30.88B
Avg. vol.
1.87M
Volume
5.31M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
www.marketscreener.com
·
1 hour ago
Alcon : Earnings Document (Q3 2026 Earnings Presentation)
marketscreener.com
·
1 hour ago
Earnings Flash (ALC) Alcon Posts Q3 Core EPS $0.91, vs. FactSet Est of $0.87
Yahoo Finance
·
1 hour ago
Innovation and Product Launch Momentum Drive Alcon’s Third-Quarter 2026 Growth
Investing.com
·
8 hours ago
Alcon earnings up next: Can product launches sustain momentum?
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com